Welcome to AlabamaLifeScience.com
AlabamaLifeScience.com is part of a specialized network of state- and province-based biotechnology, medical device,
and life science sites that includes more than 4,500 biotechnology, medical device, pharmaceutical companies,
non-profit research institutions, universities and supporting service sector companies across the U.S. and Canada.
This network addresses the growing informational and service needs of companies, patients, educators and others in
their respective states while providing clients the opportunity to cost effectively
advertise job openings, events, facility availability and other services at the state level,
regionally or nationwide for the same low rate. We welcome your comments, suggestions and requests for
informational content and supporting services.
 More...
Destination Alabama
Are you considering a move to Alabama? Relocating your business to
Alabama? Starting a company? Or just interested in Alabama?
This section will answer many of your questions regarding the life science industry in Alabama, the province's
economy, tax structure and cost of living, education, transportation, climate, recreational opportunities, history,
industry resources, and more.
More...
|
|
|
Local News...
Free News Release Posting & Archiving Service
- Nplate(TM) (Romiplostim) receives positive opinion for marketing authorisation in the EU Amgen announced that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending marketing authorisation for Nplate(TM) (romiplostim) in the European Union (EU).
Amgen November 21, 2008
- CHMP recommends approval of new indication for Enbrel(R) The European Committee for Medicinal Products for Human Use (CHMP) announced its positive recommendation for the approval of Enbrel(R) (etanercept) as a treatment for children aged 8 years and over and adolescents with severe plaque psoriasis.
Wyeth November 21, 2008
- Lilly completes cash tender offer for ImClone Systems Eli Lilly and Company and ImClone Systems announced the successful completion of the previously announced tender offer by Lilly's wholly-owned subsidiary, Alaska Acquisition Corporation, for all outstanding shares of ImClone at a price of $70.00 per share in cash.
Eli Lilly and Company November 21, 2008
- Wyeth names Michael Kamarck President, Technical Operations & Product Supply Wyeth announced that Michael Kamarck, Ph.D., 57, has been promoted to President, Technical Operations & Product Supply (TO&PS). Dr. Kamarck will be responsible for all aspects of technical operations and product supply for Wyeth.
Wyeth November 20, 2008
- Wyeth declares preferred stock dividend At a meeting of the Board of Directors of Wyeth, a dividend of fifty cents ($0.50) per share on the outstanding shares of Preferred Stock was declared payable on January 2, 2009 to stockholders of record at the close of business on December 12, 2008.
Wyeth November 20, 2008
More... | Submit News Release | National News
|
New Job Postings...
Free Job Posting Trial Offer
More... |
Job Advertising...
| About Job Postings...
|
New Facilities Available...
ATC clean room constructors...validation guaranteed!
More... |
Facility Advertising...
|
Upcoming Events...
Free Event Posting Service
 More... |
Submit Event |
Event Advertising...
|
|
Learn About Alabama's BioHistory
Why is there a biotechnology industry in Alabama? Will the industry continue
to grow in Alabama? What do other states have? Each state has a unique story
that explains why a given industry has developed in a specific region and not in others.
Through Alabama BioHistory, you can learn about the scientists,
institutions, political leaders, and significant events that have shaped and are still shaping
the biotechnology, medical device and life science industries in the state of Alabama.
More...
BioEvolution Posters
More...
November is American Diabetes Month
Diabetes is a leading cause of kidney failure, blindness and amputations, and a major cause of heart
disease and stroke. Nearly 24 million Americans have diabetes, and about one quarter (or 5.7 million)
of them don't know that they have the disease. Millions more are at risk of developing diabetes.
Diabetes is a costly disease associated with serious complications and premature death. It is a major
cause of heart disease and stroke and a leading cause of leg and foot amputations unrelated to injury,
kidney failure, and new blindness in adults.
More...
BioFact
(1889) - Johns Hopkins medical hospital in Baltimore opens.
It's a Small World
|
| |
Pollen Grain
| |
Science Quote
"Science is facts; just as houses are made of stone, so is science made of facts; but a pile of stones is not a house, and a collection of facts is not necessarily science."
| - |
Jules Henri Poincaré, French mathematician
|
|
(1854-1912)
|
|
